Group 1 - The A500 Index ETF has shown significant liquidity with a turnover rate of 4.19% and a transaction volume of 604 million yuan [3] - Over the past three months, the A500 Index ETF has experienced a scale growth of 455 million yuan, ranking first among comparable funds [3] - The A500 Index ETF has seen an increase of 804 million shares in the last three months, also ranking first in terms of new shares among comparable funds [3] Group 2 - In the past nine trading days, the A500 Index ETF has recorded net inflows of funds on five days, totaling 39.91 million yuan [3] - As of April 30, 2025, the top ten weighted stocks in the CSI A500 Index account for 20.8% of the index, including major companies like Kweichow Moutai and BYD [3] - The reduction of bilateral tariffs between China and the U.S. has positively impacted market risk appetite and improved fundamental expectations, leading to a breakout of major A-share indices [3] Group 3 - The outlook for the A-share market suggests a steady upward trend amidst fluctuations, supported by policies aimed at stabilizing and activating the capital market [4] - Initiatives such as the third batch of long-term investment trials for insurance funds and reforms in public fund management fees are expected to inject new capital into the A-share market [4] - Investors without stock accounts can access the A500 ETF through the CSI A500 ETF linked fund (022454) for exposure to the top 500 A-share companies [4]

从资金流向看，股东增持股中，近5日主力资金净流入的有8只，净流入资金最多的是汇洲智能，合计净 流入资金0.78亿元；近5日净流出资金居前的有*ST星光、东方盛虹等，净流出资金分别为0.64亿元、 0.47亿元。（数据宝） 近5日重要股东增持股一览 增持次数方面， 近5日获重要股东增持两次以上的共有4家公司， 分别是东方盛虹（增持3次）、ST新 亚（增持3次）、万里扬（增持2次）等。以增持的股东数量统计，近5日东方盛虹有3位重要股东集体出 手；其次是ST新亚、汇洲智能，分别有3位、2位股东出手增持。 板块分布显示，近5个交易日重要股东增持股中，主板包含22只，科创板有2只，增持金额上，主板增持 9.02亿元，科创板增持356.35万元。行业方面，重要股东增持股主要集中在医药生物、机械设备等行 业，分别包含3股、3股。 市场表现方面，获股东增持个股近5日平均上涨1.39%，整体强于其间沪指表现。从个股看，近5日涨幅 居前的有*ST星光、汇洲智能、辽宁成大等，涨幅分别为12.07%、7.03%、5.77%。跌幅居前的有鞍钢股 份、佛山照明等，分别下跌1.27%、1.23%。 证券时报·数据宝以股权变动日为基准进行统 ...

Summary of Key Points Core Viewpoint - As of May 16, the total market financing balance decreased to 1.79 trillion yuan, indicating a slight reduction in investor activity in the market [1]. Company and Industry Analysis - The financing balance in the Shanghai market was 907.43 billion yuan, down by 0.92 billion yuan, while the Shenzhen market's balance was 882.06 billion yuan, also down by 0.92 billion yuan. The North Exchange's financing balance decreased to 5.38 billion yuan, down by 0.038 billion yuan [1]. - On May 16, a total of 1,712 stocks received net financing purchases, with 257 stocks having net purchases exceeding 10 million yuan. Notably, 22 stocks had net purchases over 50 million yuan [1]. - The top three stocks by net financing purchases on May 16 were: - China Merchants Bank: 170.42 million yuan - Tonghua Golden Horse: 167.08 million yuan - China Ping An: 136.61 million yuan [2]. - The industries with the highest concentration of stocks receiving net financing purchases over 50 million yuan included automotive, basic chemicals, and food and beverage, each with three stocks listed [1]. - The average ratio of financing balance to circulating market value for stocks with significant net purchases was 4.01%, with Dongtu Technology having the highest ratio at 9.79% [2]. - The financing net purchase rankings on May 16 highlighted several stocks, including: - Dongtu Technology: 8.04 million yuan, 7.58% increase - Tonghua Golden Horse: 16.71 million yuan, 2.45% increase - BYD: 9.85 million yuan, 3.28% increase [2][3].

1 风险提示：测算模型失效风险；重仓股补全与实际差异较大风险；基金持仓、久期大幅度偏离的风险。基金相关信息及数据仅作为基金研究 使用，不作为募集材料或者宣传材料；本文涉及所有基金历史业绩均不代表未来表现 2 • 本周（2025/05/12-2025/ 05/16，下同），沪深300上涨1.12%，主动股票及偏股混合基金整体测算股票仓位下降0.10%，至87.66% 。 • 本周主动股票及偏股混合型基金前5大行业：电子（14.99%）、电力设备（9.28%）、医药生物（6.49%）、汽车（6.49%）、机械设备（6.29%）。 • 加仓前3大行业：国防军工(+0.50%）、非银金融(+0.35%）、计算机(+0.07%）；减仓前3大行业：医药生物(-0.20%）、轻工制造(-0.16%）、电子(- 0.11%）。 • 本周中债10年期国开债到期收益率上行5bps，中长期纯债整体测算久期中位数上升0.23，至3.02年，位于近5年的99.70%分位数。近4周平均久期 中位数为2.70年；本周久期分歧度有所上升，测算久期标准差上升0.09，至1.55年。短期纯债久期中位数上升0.01，至0.97年。 • 信用债基久 ...

Group 1 - The core viewpoint indicates that the U.S.-China tariff negotiations are in three phases: the first phase is pessimistic, the second phase shows recovery, and the third phase remains a long-term "game" with a specific order and rhythm that should not be rushed. The progress and reduction of tariffs are better than market expectations, leading to significant inflows into U.S. stocks and improved market sentiment. Currently, comprehensive tariffs from the U.S. on China remain around 50% + 24% pending, suggesting that while the "deadlock has been broken," the "final outcome is still far off" [1] - In the context of major assets recovering to their April 3 highs, A-shares are expected to maintain a period of high-level fluctuations. The report suggests focusing less on indices and more on bottom-up performance opportunities, reducing chasing of rallies and preparing for the market in June and July [1][5] - The report ranks major asset classes for the third phase of tariffs, indicating that among QDII investable assets, German stocks are preferred over Japanese and Hong Kong stocks, followed by U.S. stocks and U.S. Treasuries. Gold is suggested for short-term trading opportunities around the 3100-3150 range [1][6] Group 2 - The A-share market is experiencing a strong rebound due to the easing of U.S.-China tariff agreements, but there is a risk of subsequent pullbacks as most broad indices have filled gaps from early April, limiting upward space. The report emphasizes a strong motivation for funds to realize gains [5][36] - The report highlights that the valuation of the CSI 300 has recovered to within one standard deviation, moving away from extreme undervaluation. It also notes that public fund positions have been adjusted downwards, and the market is expected to experience short-term fluctuations with a focus on structural opportunities in dividend stocks and sectors benefiting from domestic demand [5][36] - In the Hong Kong market, trading sentiment remains low, with net selling from southbound funds. The report indicates that the focus of increased buying is on defensive sectors, while technology stocks have seen significant net selling [39][40] Group 3 - The report indicates that the U.S. stock market is showing medium-level positions, with recent economic data being mixed and not supporting stagflation assumptions. The report suggests maintaining a wave trading strategy and being cautious about profit-taking [32][36] - The report notes that the Japanese stock market has seen a significant pullback, suggesting that investors should gradually take profits as the index approaches previous highs [33] - The report emphasizes that the overall sentiment in the Hong Kong market is pessimistic, with a shift towards defensive sectors and significant selling in technology stocks. The report also highlights the recent improvement in domestic economic fundamentals, which is favorable for the Hong Kong market [39][44] Group 4 - The report suggests a focus on high-dividend cash flow and small-cap technology stocks in the A-share market, indicating a "barbell" strategy for investment. It emphasizes the importance of sector selection, particularly in banking, electricity, innovative pharmaceuticals, and robotics [36][46] - The report indicates that the small-cap style is currently favored, with short-term market interest rates declining, benefiting small-cap performance. However, it warns of potential trading crowding risks in the CSI 2000 [47] - The report highlights the ongoing demand for gold as a hedge against tariffs and potential economic weakness in the U.S. in June, suggesting that gold remains a good choice for short-term trading opportunities [48]

分析师： 周浦寒(S0210524040007) zph30515@hfzq.com.cn 研究助理： 杨逸帆(S0210124110046) yyf30689@hfzq.com.cn 策 略 研 究 华福证券 29 只医药生物主题走出见底形态 团队成员 投资要点： 策 略 定 期 报 告 主题投资数据库旨在筛选优秀量价形态的主题机会，把握热门主题的 见顶节奏、龙头股的调整程度。在 3/9 发布的《主题投资的下半场决胜法 则》中，我们构建了主题投资的数据追踪体系。我们专注于 2 方面：1）4 种形态量化筛选，高赔率的主题机会；2）构建交易热度指标，把握热门主 题的见顶节奏，并最新增加了龙头股的调整程度观察。后续，我们将定期 更新主题投资数据体系。我们希望通过这种偏量化的方式，给予投资者更 客观的参考，把握住主题投资的行情节奏。 29 只医药生物主题走出见底形态。本期走出见底、突破、主升、加速 的主题指数数量分别有 79、38、9、0 只。其中，79 只见底形态的主题指 数多为医药生物行业（29 只）；而 38 只突破形态的主题指数中，行业多 为国防军工（7 只）、通信（5 只）和有色金属（5 只）。9 只主升 ...

宏观和大类资产配置周报 中美日内瓦经贸会谈联合声明发布 我们将后续大类资产配置顺序调整为：股票>大宗>债券>货币 宏观要闻回顾 宏观经济 | 证券研究报告 — 总量周报 2025 年 5 月 18 日 资产表现回顾 ◼ 本周沪深 300 指数上涨 1.12%，沪深 300 股指期货上涨 1.06%；焦煤期货 本周下跌 2.21%，铁矿石主力合约本周上涨 4.67%；余额宝 7 天年化收益 率下跌 2BP 至 1.24%；十年国债收益率上行 4BP 至 1.68%，活跃十年国债 期货本周下跌 0.53%。 资产配置建议 ◼ 4 月新增社融 1.16 万亿元，较去年同期多增 1.22 万亿元，较 3 月少增 4.73 万亿元，略低于万得一致预期的 1.26 万亿元。4 月社融存量同比增长 8.70%，较 3 月上升了 0.37 个百分点，略低于万得一致预期的 8.80%。4 月新增人民币贷款 884 亿元，较去年同期少增 2465 亿元，较 3 月少增 3.74 万亿元。去年同期社融基数较低。较去年同期多增的是政府债券、汇票、 企业债、股票融资和外币贷款，较去年同期少增的是人民币贷款、信托贷 款和委托贷款。我们认 ...

Investment Rating - The report maintains an "Overweight" rating for the sector [1] Core Viewpoints - The market is expected to experience a period of volatility, with a focus on relative opportunities in the pharmaceutical and dividend sectors [19][21] - The model predicts a potential shift to a downward trend for the Wande All A Index, indicating a possible adjustment phase in May [19][26] - The pharmaceutical sector is highlighted for its relative stability and potential for returns, while the dividend sector is also expected to perform well after a short-term adjustment [19][21] Summary by Sections A-share Market Overview (May 12-16, 2025) - The top three broad indices were: North Certificate 50 (3.13%), Wande Micro-Pan Daily Equal Weight Index (1.58%), and ChiNext Index (1.38%) [10] - The bottom three indices were: Sci-Tech Innovation 100 (-1.29%), Sci-Tech Innovation 50 (-1.10%), and Sci-Tech Comprehensive Index (-1.00%) [10] A-share Market Outlook (May 19-23, 2025) - The Wande All A Index's daily model shifted from a positive to a negative signal on May 15, suggesting a potential adjustment phase [19][26] - The monthly model for May scored -2.5, indicating a slight adjustment in the A-share market [19][26] - The report anticipates a "V-shaped" market movement, with ongoing pressure on trading volumes [19] Fund Allocation Recommendations - The report suggests a defensive ETF allocation strategy, focusing on the pharmaceutical and dividend sectors for relative returns [19][21]

证券代码：002349 证券简称：精华制药 公告编号：2025-025 精华制药集团股份有限公司 关于 2025 年限制性股票激励计划 首次授予登记完成的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或者重大遗漏。 重要内容提示： 根据中国证监会《上市公司股权激励管理办法》、深圳证券交易所、中国证 券登记结算有限责任公司深圳分公司有关规则的规定，精华制药集团股份有限公 司（以下简称"公司"）完成了 2025 年限制性股票激励计划的首次授予登记工 作，具体情况公告如下： 一、本期激励计划已履行的相关审批程序 四次会议，审议通过了《2025年限制性股票激励计划（草案）》《2025年限制性 股票激励计划实施考核管理办法》以及《关于提请股东会授权董事会办理公司 的相关事项进行核实并出具了相关核查意见。 的姓名和职务在公司内部进行了公示，截至公示期满，对公示名单人员没有任何 组织或个人对激励对象名单提出异议。有个别员工建议扩大激励对象范围。2025 年4月28日，公司披露了《监事会关于2025年限制性股票激励计划激励对象名单 证券代码：002349 证券简称：精华制药 公告编 ...

以最新收盘价计算，科创板平均股价为29.78元，其中股价超100元的有34只，股价最高的是寒武纪。 证券时报·数据宝统计显示，科创板股今日上涨的有354只，下跌的有222只，以收盘价为基准测算，科 创板平均股价为29.78元，其中，收盘价超过100元的有34只，股价在50元至100元之间的有104只，股价 在30元至50元的有151只。 （文章来源：证券时报网） | 代码 | 简称 | 最新收盘价（元） | 今日涨跌（%） | 换手率（%） | 行业 | | --- | --- | --- | --- | --- | --- | | 688256 | 寒武纪 | 668.00 | -1.33 | 0.86 | 电子 | | 688617 | 惠泰医疗 | 406.91 | -1.78 | 0.41 | 医药生物 | | 688608 | 恒玄科技 | 404.11 | -0.71 | 1.37 | 电子 | | 688692 | 达梦数据 | 324.52 | -1.74 | 3.49 | 计算机 | | 688111 | 金山办公 | 290.45 | 0.14 | 0.47 | 计算机 | | 68850 ...